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Abstract: Curcumin is a potent natural anticancer agent, but its effectiveness is limited by 
properties such as very low solubility, high rate of degradation, and low rate of absorption of 
its hydrophobic molecules in vivo. To date, various nanocarriers have been used to improve 
the bioavailability of this hydrophobic biomaterial. This study investigates the encapsulation of 
curcumin in a novel nanostructure of monomethoxy poly(ethylene glycol)-oleate (mPEG-OA) 
and its anticancer effect. Tests were done to determine the critical micelle concentration 
(CMC), encapsulation efficiency, drug-loading efficiency, and cytotoxicity (against U87MG 
brain carcinoma cells and HFSF-PI3 cells as normal human fibroblasts) of some nanodevice 
preparations. The results of fluorescence microscopy and cell-cycle analyses indicated that 
the in vitro bioavailability of the encapsulated curcumin was significantly greater than that of 
free curcumin. Cytotoxicity evaluations showed that half maximal inhibitory concentrations of 
free curcumin and curcumin-loaded mPEG-OA for the U87MG cancer cell line were 48 μM 
and 24 μM, respectively. The Annexin-V-FLUOS assay was used to quantify the apoptotic 
effect of the prepared nanostructures. Apoptosis induction was observed in a dose-dependent 
manner after curcumin-loaded mPEG-OA treatments. Two common self-assembling structures, 
micelles and polymersomes, were observed by atomic force microscopy and dynamic light scat-
tering, and the abundance of each structure was dependent on the concentration of the diblock 
copolymer. The mPEG-OA micelles had a very low CMC (13.24 μM or 0.03 g/L). Moreover, 
atomic force microscopy and dynamic light scattering showed that the curcumin-loaded 
mPEG-OA polymersomes had very stable structures, and at concentrations 1,000 times less 
than the CMC, at which the micelles disappear, polymersomes were the dominant structures in 
the dispersion with a reduced size distribution below 150 nm. Overall, the results from these 
tests revealed that this nanocarrier can be considered as an appropriate drug delivery system 
for delivering curcumin to cancer cells. 
Keywords: anticancer agent, nanocarrier, encapsulation, bioavailability, apoptosis, critical 
micelle concentration
Introduction
Extensive and detailed investigations have been made in recent decades on cancer 
treatments, but cancer still remains a leading cause of many deaths worldwide.1 Chemo-
therapeutic strategies used to treat cancer commonly target a specific pathway and are 
effective for shrinking tumor size, but are often not able to completely destroy a tumor 
or prevent its recurrence. In addition, these strategies usually are not effective against 
resistant tumor cells. It is, therefore, important that a candidate anticancer agent be able 
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to target multiple cellular signaling pathways with the lowest 
possible toxicity to normal cells. Of these anticancer agents, 
natural products and extracts have shown good potential 
and results.2 Curcumin is derived from turmeric (Curcuma 
longa). It is a natural extract and as such represents a good 
candidate for anticancer treatment. Traditionally, turmeric 
and its derivatives have been used extensively in Eastern 
countries as a food additive and for various medicinal pur-
poses. In recent decades, several researchers have reported 
the anticancer effect of curcumin.3–5 The effect of curcumin 
on cancer cells was found to be related to multiple cell-
signaling pathways and prevention of the processes of cell 
proliferation, invasion, metastasis, and angiogenesis. How-
ever, some properties of curcumin such as very low water 
solubility and bioavailability hamper its suitability for use in 
cancer therapy. In this regard, the application of nanocarriers 
represents a good solution for curcumin delivery to cancer 
cells. An extensive review on curcumin nanoformulations 
has been published by Yallapu et al.2
Much research has been published recently on polymeric 
micelles as a strategy for drug delivery.6,7 Amphiphilic block 
copolymers can self-assemble in an aqueous solution to form 
micellar structures. The hydrophilic surface layers of micelles 
may consist of polyethylene glycol (PEG) chains that can hinder 
the interaction between hydrophobic compartments and biologi-
cal membranes, and prevent adsorption of plasma proteins onto 
nanoparticle surfaces. This effect significantly reduces nanopar-
ticle recognition and elimination by the immune system.8 
Different kinds of high-molecular weight amphiphilic 
block copolymers have been utilized to form polymersomes. 
Polymersomes generally have a thick and versatile mem-
brane. The physical and chemical properties of polymer-
somes can be tuned by using various and appropriate block 
lengths and chemical structures. Manipulating the elasticity 
and permeability of polymersome membranes can produce 
high stability in comparison to liposomes and simple lipid-
based vesicles formed by low-molecular weight surfactants 
and lipids.7,9,10 Furthermore, as a general rule, it is now clearly 
evident that amphiphilic block copolymers can form vesicles 
(polymersomes) at the hydrophilic domain to a total mass 
ratio (ƒ) of about 35%±10%.11
Previous studies by our group have demonstrated that cur-
cumin encapsulated in dendrosome, a diblock nanostructure 
made of oleic acid and PEG (400 Da), can kill cancer cells 
through the apoptosis pathway and significantly reduce tumor 
size in mice.12,13 In the present study, the dendrosome structure 
applied was modified in order to obtain better thermodynamic 
stability. This modification was made by using monomethoxy 
PEG (mPEG) of a higher molecular weight (mol wt) of 2,000 
Da, and the self-assembled structures were used as the encapsu-
lating structures for curcumin. According to our results, based 
on measurements of critical micelle concentration (CMC), 
calculated loading and encapsulation efficiencies, and results 
of other performed cellular experiments, this novel small, 
hydrophobic fraction copolymer (ƒ≈85%) vesicular nanocar-
rier can be considered an appropriate drug delivery system for 
curcumin delivery to cancer cells. 
Methods
Materials
Curcumin, pyrene, triethyl amine, and chloroform were 
purchased from EMD Millipore (Billerica, MA, USA). 
Oleoyl chloride and mPEG (mol wt 2,000 Da) were pur-
chased from Sigma-Aldrich Co., (St Louis, MO, USA). 
The Annexin-V-FLUOS/propidium iodide (PI) staining 
kit was purchased from Hoffman-La Roche Ltd., (Basel, 
Switzerland). All materials were used as received without 
any further purification. All solvents used in tests were of 
analytical grade and obtained from EMD Millipore. 
synthesis of mPeg-Oa conjugate 
The mPEG-oleate (OA) was synthesized by esterification of 
oleoyl chloride (3.01 g, 0.01 mol) and methoxy PEG 2,000 
(20 g, 0.01 mol) in the presence of triethyl amine (1.2 g, 
0.012 mol) and chloroform as the solvent, at 25°C for 2 hours. 
The conjugate was characterized by proton nuclear magnetic 
resonance imaging (1H NMR) (spectra were recorded in 
dimethyl sulfoxide [DMSO] on a Bruker DRX 400 MHz 
apparatus; Bruker Optik GmbH, Ettlingen, Germany) and 
Fourier transform infrared (FT-IR) spectroscopic analyses 
(PerkinElmer Inc., Waltham, MA, USA). 
Determination of cMc 
The CMC of mPEG-OA was determined by the pyrene fluo-
rescence absorbance spectral shift as described by Sahu et al.14 
First, 3 mL of a pyrene solution (10-6 M) in acetone was poured 
into a glass test tube, and then the solvent was removed. Next, 
5 mL of various concentrations of mPEG-OA copolymer in 
phosphate buffered saline (PBS) (0.01 M, pH 7.4), ranging 
from 0.005–1 mg/mL, was added to prepare the final pyrene 
solution of 6.0×10-7 M. The evaluation was made for the fluo-
rescence spectra of pyrene (300–350 nm for excitation, with 
slit widths of 2.5 nm at an emission wavelength of 390 nm with 
slit widths of 5.0 nm). The fluorescence excitation shifts within 
the range of 334–339 nm were used to determine the CMC of 
mPEG-OA nanocarriers (PerkinElmer fluorimeter).
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Physical properties of particles: size, 
morphology, and zeta potential
Dynamic light scattering (DLS) and atomic force microscopy 
(AFM) studies were performed to determine the physical 
properties of the mPEG-OA nanocarriers. The zeta potential, 
size, and polydispersity index (PDI) of curcumin/mPEG-OA 
(Cur/mPEG-OA) nanocarriers in PBS (0.01 M, pH 7.4) were 
analyzed by DLS (Zetasizer Nano ZS; Malvern Instruments, 
Malvern, UK) using an argon laser beam at 633 nm and a 
90° scattering angle. The shape of the nanocarriers was char-
acterized by AFM (JPK Instruments AG, Berlin, Germany), 
as described by Darvishi et al.15
Curcumin encapsulation efficiency 
and drug-loading content
The encapsulation efficiency (EE) and drug-loading (DL) of 
curcumin were measured as described by Gou et al.16 Curcumin 
(0 mg, 2 mg, 4 mg, 6 mg, 8 mg, 12 mg, 16 mg, 20 mg, and 25 
mg) and mPEG-OA copolymer (100 mg) were codissolved in 
3 mL of acetone in different glass tubes. Then, 3 mL of water 
was added to each tube with constant stirring. Next, the acetone 
was evaporated using two methods: rotary evaporation (45 
minutes) and overnight incubation in a shaker at 37°C. After 
that, samples were filtered using a syringe filter (pore size: 
0.22 μm) (Jet Bio-Filtration Products, Co., Ltd., Guangzhou, 
People’s Republic of China) to remove any undissolved cur-
cumin. Each of the prepared solutions was lyophilized, and 
then 10 mg of lyophilized Cur/mPEG-OA nanocarrier was 
dissolved in 1 mL of methanol. Samples were then shaken 
vigorously for 2 minutes followed by 10 minutes of sonication 
in an ultrasonic water bath for disruption of the nanocarrier 
structures. The amount of curcumin in the solution was quanti-
fied spectrophotometrically at 425 nm (NanoDrop® UV–Vis 
spectrophotometer; Thermo Fisher Scientific, Waltham, MA, 
USA). Finally, evaluations were made for the DL and EE of 
Cur/mPEG-OA according to the following equations:
 
EE %
Weight of curcumin in nanocarrier
Weight of feedingcurcumin
( ) = ×100  (1)
 
DL %
Weight of curcumin in nanocarrier
Weight of total nanocarrie
( ) =
r
100×  (2)
Nanostructure stability assay
Different samples of Cur/mPEG-OA aqueous dispersions 
were maintained separately at 4°C and room temperature 
for durations of 24 hours and 6 months. The stability of 
each dispersion was examined by the naked eye and DLS. 
Any precipitation was regarded as instability.16 Moreover, 
the lyophilized samples were redissolved in water by simple 
manual shaking, and then evaluations of particle size and size 
distribution were carried out by DLS.17
In vitro cytotoxicity
The U87 human glioblastoma cell line (U87MG) and human 
normal fibroblastic cells (HFSF-PI3) were obtained from 
the Pasteur Institute (Tehran, Iran) and cultured in Gibco® 
Roswell Park Memorial Institute (RPMI) 1640 medium and 
Gibco® high-glucose Dulbecco’s Modified Eagle’s Medium 
(Thermo Fisher Scientific), respectively. Media were supple-
mented with 10% v/v fetal bovine serum, 1% L-glutamine, 
and 1% penicillin/streptomycin (all purchased from Thermo 
Fisher Scientific). All cells were maintained at 37°C in a 
humidified 5% CO
2
 atmosphere.
The cellular toxicity of nanocarriers was assessed using 
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay (Sigma-Aldrich Co.) according to 
the manufacturer’s instructions. Briefly, U87MG cells 
(1×104 cells/well) and HFSF-PI3 cells (1.5×104 cells/well) 
were seeded in 96-well plates. Twenty-four hours after cell 
seeding, cells were treated with different concentrations 
(0–50 μM for U87MG and 0–100 μM for HFSF-PI3 cells) of 
free curcumin, mPEG-OA-encapsulated curcumin, and void 
mPEG-OA nanocarriers. Curcumin stock solution (100 μM) 
in DMEM was prepared from 10 mM curcumin in methanol. 
The methanol percentage in the final solutions was kept 
lower than 0.4% v/v. After incubation periods of 24 hours 
and 48 hours, media containing the treatment agents were 
carefully removed and 20 μL medium containing 5 mg/mL 
MTT in PBS was added to each well. After 4 hours at 37°C, 
the medium was gently removed and 200 μL DMSO was 
added to each well. The absorbance, which was proportional 
to the cell viability, was subsequently measured at 490 nm 
in each well using an enzyme-linked immunosorbent assay 
plate reader. All values were compared to the corresponding 
controls. Cell viability was calculated as the percentage of cell 
viability of treated cells relative to that of the control cells.
Fluorescence microscopy 
and cell-cycle analysis
Fluorescence microscopy and flow cytometry were applied 
to evaluate the uptake of curcumin or curcumin nanocarriers 
in U87MG cells. For both fluorescence microscopic and cell-
cycle analyses, 105 U87MG cells were seeded in 12-well plates 
24 hours prior to the treatment, and cells were treated with 
30 μM curcumin, void nanocarriers, or 22 μM Cur/mPEG-OA, 
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while the cells were incubated at 37°C in a humidified 5% 
CO
2
 incubator. After treatment, the cells were subjected to 
visual evaluation by fluorescence micro scopy (Nikon Corpora-
tion, Tokyo, Japan) based upon the intrinsic fluorescence of 
curcumin. For this, after 4 hours of treatment and two gentle 
washes with PBS, cells were subjected to visual evaluation 
(fluorescence microscopy; Nikon Corporation) of cell uptake. 
For cell-cycle analyses, the medium was first replaced with 
fresh media containing the mentioned concentrations of cur-
cumin, void nanocarriers, or Cur/mPEG-OA. After incubation 
for 24 hours, cells were collected, washed twice with cold 
PBS, and fixed with ice-cold 70% ethanol at 4°C overnight. 
After washing twice with cold PBS, cells were resuspended 
in PBS containing 50 μg/mL of PI, 0.1% sodium citrate, and 
0.1 Triton X-100 followed by shaking at 37°C for 15 minutes. 
The DNA content of the samples was analyzed using a flow 
cytometer (BD FACSCantoTM II; BD Biosciences, San Jose, 
CA, USA).18 For flow cytometric and cell-cycle analyses, at 
least 10,000 events were counted for each measurement, and 
data were evaluated using Flowing Software 2.5.1 (Turku 
Centre for Biotechnology, University of Turku, Turku, Fin-
land). The percentages of cells in each phase of the cell cycle 
were determined from the results of three tests and expressed 
as means ± standard deviations. Means were compared using 
the least significant difference test (P0.05) by SAS software 
(version 9.1; SAS Institute Inc., Cary, NC, USA). 
apoptosis detection
The apoptotic index of each sample was measured through 
flow cytometric assays using Annexin-V-FLUOS and PI 
staining kits (Hoffman-La Roche Ltd.) according to the 
manufacturer’s instructions. Briefly, U87MG cells were seeded 
(0.3×106 cells/well) into six-well plates and allowed to adhere 
overnight before treatment with the desired concentrations of 
Cur/mPEG-OA or blank mPEG-OA for 24 hours. Trypsin-
digested cells were centrifuged at 200× g for 5 minutes. The cell 
pellet was resuspended in 100 μL of Annexin-V-FLUOS label-
ing solution, incubated for 10–15 minutes at 15°C–20°C, and 
immediately analyzed using a CyFlow Space Flow Cytometer 
(Partec GmbH, Münster, Germany). The data were evaluated 
using FSC Express Software version 4.07 (Demo Version of 
Research Edition; De Novo Software, Glendale, CA, USA).
Results and discussion
FT-Ir and NMr assays
The synthesis of mPEG-OA diblock monomers was con-
firmed by FT-IR (Figure 1) and NMR (Figure 2) spectro-
scopy. Figure 1 shows the FT-IR spectrum of freeze-dried 
powder of synthesized mPEG-OA. It demonstrates the 
stretching bands of C-H aliphatic at 2,889 cm-1, 2,947 cm-1, 
and 2,960 cm-1. The C-H bending vibration of CH
2
 and C-H 
bending vibration of CH
3
 were determined at 1,467 cm-1 
and 1,343 cm-1, respectively. The broad band C-O stretch-
ing vibration was evident at 1,112 cm-1, and the signal at 
1,736 cm-1 showed the C=O stretching vibration of ester 
bands between oleic acid and mPEG.
Figure 2 shows the 1H NMR spectrum of mPEG-OA 
dissolved in DMSO-d
5
. The saturated proton signals of fatty 
ester were obvious at 0.8 ppm, 1.2 ppm, 1.5 ppm, 2 ppm, 
and 2.3 ppm. The residual DMSO-d
5
 signal was at 2.5 ppm. 
The DMSO-d
5
 water impurity was observed at 3.3 ppm as 
a broad band. The CH
3
 protons of mPEG were identified at 
3.2 ppm. The multiplet signals at 3.5 ppm were related to 
the CH
2
 protons of ethylene oxide units of mPEG. The CH
2
 
protons of ethylene oxide of mPEG
 
connected to fatty acid 
were detected at 4.1 ppm and 4.2 ppm. Unsaturated protons 
of oleate were present at 5.3 ppm. All of these FT-IR and 
1H NMR findings indicate that the mPEG-OA structure was 
correct and the synthesis was carried out properly. 
cMc of nanocarriers
From the crossover point in Figure 3, the CMC of nanocar-
riers was determined to be 13.24 μM (0.03 g/L), which is 
much lower than the CMC of common low-molecular weight 
surfactants such as 2.3 g/L for sodium lauryl sulphate in water. 
It is four times lower than the CMC of mPEG-palmitate copo-
lymers, which has been reported to be 53.3 μM (0.12 g/L).14 
Such a low value of CMC for mPEG-OA implies the latent 
thermodynamic stability of micelles and may increase the 
Figure 1 Fourier transform infrared spectra of mPeg-Oa nanocarriers. 
Notes: (A) Oa, (B) mPeg, and (C) mPeg-Oa nanocarriers as a freeze-dried 
powder. The peak at 1,736 cm-1 shows the esteric bond between Oa and mPeg.
Abbreviations: mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate; Oa, oleic 
acid; mPeg, monomethoxy poly(ethylene glycol).
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stability of the micelles after in vivo dilution. This may 
result in an enhanced blood circulation time of the prepared 
nanostructures, which usually is favorable for drug delivery 
and tumor tissue targeting.14,19 
Encapsulation and DL efficiencies
Various amounts of curcumin (from 2–25 mg) were loaded 
into 100 mg mPEG-OA nanocarriers in dispersion. The soluble 
Cur/mPEG-OA complexes were filtered through a 0.22 μm 
filter in order to remove any insoluble curcumin. The filtrate 
obtained was freeze-dried to obtain solid complexes, and then 
drug encapsulation was confirmed by FT-IR spectroscopy 
of the freeze-dried samples (Figure 4). Curcumin shows a 
carbonyl band at 1,628 cm-1, and we can see this band in 
curcumin-encapsulating mPEG-OA (freeze-dried powder), 
a physical mixture of the void mPEG-OA nanocarriers and 
free curcumin. The presence of bands at 1,628 cm-1 and 
1,736 cm-1 in the Cur/mPEG-OA spectrum provided evi-
dence that the encapsulation took place appropriately.
The EE (Figure 5A) and DL (Figure 5B) were determined 
to be 87.1%±7.7% and 5.22%±0.46%, respectively, for the 
ratio of 0.06% (curcumin:mPEG-OA w/w). The EE for 
mPEG-palmitate at a 0.05% w/w ratio (curcumin:nanocarrier) 
was reported to be about 30%.14 However, in this study, the 
EE of curcumin:nanocarrier w/w ratio of 0.06% was signifi-
cantly higher (EE of more than 80%). Moreover, although 
it seems that the amount of 8.8% is the maximum achieved 
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Figure 3 Determination of cMc of mPeg-Oa.
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Abbreviations: mPeg, monomethoxy poly(ethylene glycol); cMc, critical micelle 
concentration; mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate.
A
Excitation wavelength (nm)
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 (a
u) mPEG – control0.005 g/L
0.125 g/L
0.500 g/L
1 g/L
0
33
2
33
3
33
4
33
5
33
6
33
7
33
8
33
9
34
0
34
1
34
2
34
3
34
4
34
5
34
6
34
7
34
8
34
9
35
0
200
400
600
I (3
39
/3
34
)
Log C (g/L)
2.2
2.1
2.0
1.9
1.8
1.7
1.6
1.5
1.4
1.3
1.2
1.1
1.0
0.9
0.8
0.7
0.6
–3
.0
0
–2
.7
5
–2
.5
0
–2
.2
5
–2
.0
0
–1
.7
5
–1
.5
0
–1
.2
5
–1
.0
0
–0
.7
5
–0
.5
0
–0
.2
5
0.
00
mPEG-OA
mPEG (control)
B
International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5546
erfani-Moghadam et al
DL (Figure 5), the DL of 6% was found to be more stable 
than that of 8%. This was revealed by the incubation of 
the samples for 24 hours at 4°C; after this incubation time, 
some curcumin precipitation was observed in samples 
with a DL greater than 8%. These results indicated that the 
curcumin:nanocarrier w/w ratio of 0.06% was an appropriate 
ratio for the following experiments. 
Physical properties of particles: size, 
morphology, and zeta potential
Evaluations of size, zeta potential, and morphology of the 
nanocarriers were determined by DLS and AFM, and the 
results are presented in Figure 6 and Table 1. Generally, 
the results showed that mPEG-OA had two particle forms, 
micelles and polymersomes, both of which were spherical 
in shape. The DLS results showed that the mean size of the 
micelles was 18.33±5.32 nm and that of the polymersomes 
was 99.4±65 nm. 
Interestingly, according to Figure 6, the DLS data showed 
a relative monodispersity of mPEG-OA nanocarriers when 
they were stored for 1 week at room temperature (mean 
PDI =0.182±0.072 with 100% polymersomes with a mean 
size of 100±42.6 nm). However, the DLS and AFM results 
revealed that the curcumin-loaded mPEG-OA polymer-
somes could be observed even when the concentration of 
copolymer was 1,000-fold below that of CMC (13.24 nM or 
3×10-5 g/L). Although the populations of both forms of par-
ticles (ie, micelles and polymersomes) increased at the higher 
concentrations, the increase in the micellar form appears to 
have been more than that of polymersomes (Figure 7 and 
Table 1). At concentrations lower than the CMC, the popula-
tion of polymersomes decreased less than that of micelles, 
which means that this form was stable even at concentrations 
much lower than the CMC. Pearson et al20 reported that, in 
general, micelles are thermodynamically unstable and that 
they tend to join together and form polymersomes, which 
are more stable than micelles. 
The negative zeta potential of mPEG-OA nanostructures 
(-32.6±11.1 mV) induced by oleate blocks in the copolymer 
structure seems to be adequate for particle stability and uni-
form size distribution.
There is a significant difference between the dynamics 
of micelle and vesicle formation/breakdown. Micelles can 
form quite quickly – that is, in less than a second for most 
micellar systems. For vesicles of synthetic surfactants, this 
Figure 4 Fourier transform infrared spectra of curcumin, void mPeg-Oa 
nanocarriers, curcumin encapsulated in mPeg-Oa nanocarrier, and a physical 
mixture of curcumin with void mPeg-Oa nanocarriers. 
Notes: (A) curcumin, (B) void mPeg-Oa nanocarriers, (C) cur/mPeg-Oa 
(encapsulated curcumin) as a freeze-dried powder, and (D) physical mixture of 
curcumin and void mPeg-Oa nanocarriers. 
Abbreviations: mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate; cur/
mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate.
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formation needs a time duration of several seconds to a 
minute, although a millisecond time period is just enough for 
surfactant monomer exchange between vesicles and aqueous 
solution.21 Pearson et al20 also described some examples of 
micelle-to-vesicle transition according to block length and 
hydrophilic content that leads to the formation of intermediate 
structures such as “jellyfish” and “octopus” aggregates, 
which are precursors to polymersomes. Zana22 reported that 
micelles constantly form and break down in solution, and at 
a very low concentration close to the CMC, surfactants start 
forming micelles that may turn into vesicles under increas-
ing concentrations. Robinson and Zana21 discussed that the 
dynamics of micelle-to-vesicle transformations could be very 
slow and often what is studied (from 1 second to days) is the 
evolution of vesicle structures. They recommended direct 
observation of the evolution of intermediate morphologies by 
cryo-transmission electron microscopy. In our AFM experi-
ments, the time scale of minutes in the sample preparation 
was enough to develop micelles and polymersomes sepa-
rately, but this duration was not enough for micelle-to-vesicle 
transformations. Moreover, at very low concentrations such 
as 13.24 nM or 3×10-5 g/L (1,000-fold more dilute than the 
CMC of the copolymer), tests showed that the remaining 
stable particles must be small polymersomes (150 nm in 
size; Figure 8).
Previous studies indicate that polymersomes made from 
large amphiphilic diblock copolymers are more stable and 
much less water permeable compared to phospholipids 
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Table 1 Dls results for particle size and polydispersity index of mPeg-Oa nanocarriers
Particle size (nm) Polydispersity 
indexMicelles Polymersomes
Blank mPEG-OA
0% Fresh
22 μM
16.75±4
(56.9%)
51.85±15.6
(36.6%)
301±112
(6.6%)
0.47±0.071
Fresh
66 μM
44±23.8
(74%)
290±136
(26%)
0.418±0.06
Fresh
440 μM
32.4±41.8
(99.4%)
0.47±0.05
after 1 week 84.4±25.7
(100%)
0.182±0.07
Curcumin encapsulated in mPEG-OA nanocarriers (0.05 mg/mL)
5% Fresh 18.1±4
(76.3%)
72.1±30.8
(23.7%)
0.38±0.06
after 1 week 85.9±33
(100%)
0.1±0.02
10% Fresh 17.5±3.7
(87.2%)
95.7±45.2
(12.7%)
0.33±0.05
after 1 week 117±47
(100%)
0.131±0.05
15% Fresh
22 μM
19.6±5.5
(49.5%)
105.5±70.2
(50.5%)
0.332±0.03
Fresh
0.44 μM
154±93
(100%)
0.21±0.02
Fresh
0.044 μM
131±85.5
(100%)
after 1 week 129±58
(100%)
0.196±0.037
20% Fresh 22.7±6.8
(84.2%)
133±54
(15.8%)
0.41±0.2
after 1 week 132±62
(100%)
0.131±0.06
25% Fresh 69.2±27.5
(58.7%)
319±135
(41.3%)
0.57±0.07
after 1 week 109±26.7
(100%)
0.249±0.06
Notes: size is measured as hydrodynamic diameter. all data are shown as volume % versus mean size ± standard deviation (n3).
Abbreviations: Dls, dynamic light scattering; mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate; n, number.
in liposomes,23 and the shape and formation of micelle 
or polymersome vesicles are commonly determined by 
the relative hydrophobicity and geometry of the polymer 
blocks.9,24,25 Discher and Ahmed11 described a starting point 
rule that says when the hydrophilic segment of a block 
copolymer constitutes more than 50% of the whole block, 
copolymer monoblocks tend to form conical structures, 
and spherical micelles can probably be expected in the 
solution. Additionally, the report briefly mentioned that 
sometimes micelles and polymersomes can be observed 
together in a dispersion. In the case of mPEG-OA, with 
a hydrophilic part constituting approximately 85%, the 
results of these tests proved the coexistence of both forms 
at the CMC; furthermore, the micelle/polymersome ratio 
was  concentration dependent. For this diblock copolymer 
with a small hydrophobic portion, the aforementioned rule 
expressed by Discher and Ahmad11 is applicable only at con-
centrations higher than the CMC, where the micellar form is 
predominant (Figure 7A). However, at concentrations lower 
than CMC, the polymersome ratio begins to increase until 
they are the dominant form, for example at concentrations 
between 13.24×10-1 μM and 13.24×10-3 μM (or 10-3 g/L 
and 10-5 g/L; Figure 7B). 
Besides concentration, the polymersome ratio is also 
dependent on the storage time. For example, for the samples 
of 22 μM or 0.05 g/L, the volume of particles increased 
after 1 week of storage at room temperature (Figure 6 and 
Table 1). In this case, the micellar population disappeared 
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and only polymersomes were formed. Therefore, in con-
trast to previous reports, it seems that according to the 
concentration and storage time, the small hydrophobic 
part of the diblock copolymers can mainly develop into 
polymersomes.
stability of nanostructures
After 1 week at room temperature, the monodispersity of 
mPEG-OA nanocarriers increased, as the PDI of samples 
decreased from 0.47±0.071 to 0.182±0.07 (Figure 6 and 
Table 1). This increase in monodispersity indicates the sta-
bility of the mPEG-OA nanocarriers. Moreover, when the 
lyophilized samples were redissolved in water by manual shak-
ing, the micelle/polymersome size distributions were not sig-
nificantly changed from those of the freshly prepared samples 
(as measured by DLS). Except for some exceptional curcumin 
precipitation at DL levels higher than 6% within a few days, 
A B
Vo
lu
m
e 
(%
)
Vo
lu
m
e 
(%
)
26
24
22
20
18
16
14
12
10
8
6
4
2
0
1 10 100 1,000 1 10 100 1,00010,000
14
12
10
8
6
4
2
0
Size (diameter. nanometer)
Size distribution (“Volume %” vs “size”) Size distribution (“Volume %” vs “size”)
Size (diameter. nanometer)
Cur/mPEG-OA – 0.025 g/L
(concentration close to CMC point)
Cur/mPEG-OA – 0.125 g/L
Cur/mPEG-OA – 0.250 g/L
Cur/mPEG-OA – 0.500 g/L Cur/mPEG-OA – 1.25×10
–3 g/L
Cur/mPEG-OA – 1.25×10–4 g/L
Cur/mPEG-OA – 1.25×10–5 g/L
Figure 7 Dls diagram of the effect of concentration on mPeg-Oa nanocarrier size and polydispersity. 
Notes: (A) at concentrations higher than the cMc where the micellar form is predominant; and (B) at concentrations lower than the cMc where the polymersome ratio 
begins to increase until polymersomes become the dominant form.
Abbreviations: cur/mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate; Dls, dynamic light scattering; mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate; 
cMc, critical micelle concentration.
Figure 8 aFM analysis of cur/mPeg-Oa performed at 1,000-fold dilution compared 
to the cMc. 
Notes: cur/mPeg-Oa nanocarrier (13.24 nM or 3×10-5 g/l) redissolved after freeze-
drying. Most of cur/mPeg-Oa nanoparticles are smaller than 150 nm in diameter.
Abbreviations: aFM, atomic force microscopy; cur/mPeg-Oa, curcumin/mono-
methoxy poly(ethylene glycol)-oleate; cMc, critical micelle concentration.
0 2 4 6 8 10
0 0.5 1 1.5
112
19
85
102
110
123 nm
135
2 µm
µm
Cur/mPEG-OA nanocarriers were quite stable and transparent 
even after 10 months of storage at 4°C (Figure 9).
cell toxicity
According to the MTT assay results for U87MG cells, the half 
maximal inhibitory concentration (IC
50
) of the free curcumin 
solution was 48 μM, whereas the IC
50
 values for curcumin-
loaded mPEG-OA at 24 hours and 48 hours posttreatment 
were 24 μM and 15.5 μM, respectively (Figure 10A). No 
significant toxicity was observed for void mPEG-OA nano-
carriers even at a carrier concentration of 50 μM. These find-
ings indicate that the encapsulation of curcumin within the 
mPEG-OA nanocarriers significantly increased the anticancer 
effect of curcumin (P0.05; Figure 10). These results are in 
accordance with the reported cell toxicities of dendrosome-
encapsulated curcumin.13 The higher level of toxicity of 
curcumin nanocarriers in our study could be attributed to 
the higher cellular internalization of encapsulated curcumin 
through mechanisms such as endocytosis. Interestingly, Sahu 
et al14 reported a similar cytotoxicity for a block copolymer 
assembly containing curcumin. They reported IC
50
 values of 
15.58 μM and 14.32 μM for mPEG–palmitate-encapsulated 
curcumin and free curcumin, respectively, against HeLa cells. 
Consequently, in comparison with our results, it seems that 
while HeLa cells are more sensitive to free curcumin, both 
U87MG and HeLa cells exhibit almost the same sensitivity 
to curcumin nanocapsules at 48 hours posttreatment.
Based on the results of the cell toxicity evaluations, the 
IC
50
 values of curcumin-loaded mPEG-OA were greater 
than the CMC. Therefore, it seems that only when the 
micelles develop does the anticancer effect become signifi-
cant. This may indicate that the micelles are more effective 
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than polymersomes in terms of biological activity of the 
mPEG-OA delivery system. As shown in Figure 10, the 
viability curve at 48 hours of treatment surpassed that at 
24 hours with a concentration of 25 μM or higher. It is not 
clear why this happens, but we assume that over an extended 
exposure period, the cancer cells can become slightly resis-
tant to the drug and can adapt to the toxic situation, thus 
showing better survival and proliferation. Another potential 
reason is related to the stability of the curcumin within this 
time period. As indicated in a previous study,26 curcumin 
is an unstable molecule that can be degraded within hours 
to days, depending on the medium in which it is dissolved. 
Wang et al26 showed that about 90% of curcumin degrades 
within 30 minutes in a serum-free medium (pH 7.2, 37°C) and 
about 50% degrades within 8 hours in a cell culture medium 
containing 10% serum (pH 7.2, 37°C). Therefore, curcumin 
degradation could be responsible for the lower cytotoxicity 
at the later exposure time. However, further evaluations are 
needed to reach a cogent conclusion on this topic.
The mPEG-OA carrier was not toxic to normal fibro-
blastic cells. According to Figure 10B, at an effective dose 
for anticancer activity (below 25 μM) and even at 50 μM, 
curcumin and void mPEG-OA carrier were not significantly 
toxic to normal human fibroblastic cells (HFSF-PI3). These 
results show that the mPEG-OA carrier has very low toxicity 
to normal cells, and curcumin encapsulated in mPEG-OA was 
specifically toxic to U87MG cancer cells. These findings are 
in accordance with previous studies showing that curcumin 
kills tumor cells selectively.27 
Fluorescence microscopy 
and cell-cycle analysis
Fluorescence microscopy showed that mPEG-OA nanocarri-
ers significantly improved the internalization of curcumin in 
Figure 9 cur/mPeg-Oa nanocarrier transparency over time. 
Notes: mPeg-Oa nanocarrier remained transparent after 300 days of storage at 4°C, although loading efficiencies higher than 6% resulted in some curcumin precipitation 
in the prepared formulations.
Abbreviations: cur/mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate; mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate.
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U87MG cancer cells (Figure 11). The effects of curcumin and 
Cur/mPEG-OA on cell-cycle distribution were evaluated by 
flow cytometry after cells were stained with PI. To gain further 
insight into the mechanism of the growth inhibition of Cur/
mPEG-OA, U87MG cells were treated with concentrations 
close to the IC
50
 (22 μM) determined by the MTT assay. 
It has been reported that curcumin enhances expression of 
tumor cyclin-dependent kinase inhibitors, p21 and p27, as 
well as the tumor suppressor protein, p53. Moreover, it can 
induce G0/G1 and/or G2/M phase cell-cycle arrest in multiple 
human tumor cell lines.27 Additionally, for U87MG cells, some 
reports have noted cell accumulation in the sub-G1 cell-cycle 
phase.27 According to our previous study,13 with respect 
to treatment with curcumin encapsulated in dendrosomes 
(a self-assembling structure similar to the mPEG-OA of the 
present study), the cell population in the sub-G1 phase was 
significantly increased (P0.05) in comparison to the control. 
This has also been reconfirmed by the present study in which 
Cur/mPEG-OA (22 μM curcumin) led to sub-G1 cell-cycle 
arrest (5.35%±0.84%), more so than 30 μM free curcumin 
(3.56%±0.07%) or untreated control (1.55%±0.55%) in 
U87MG cells (Table 2). The difference between the sub-G1 
arrested cell populations with Cur/mPEG-OA and the untreated 
control was significant (P0.05). Additionally, similar to 
previous findings on curcumin,27,28 treating cells with Cur/
mPEG-OA can cause a significant increase in the cell popula-
tion in the G2/M phase. Cur/mPEG-OA (22 μM curcumin) 
led to G2/M phase arrest (32.23%±0.8%), obviously more so 
than 30 μM free curcumin (18%±0.56%) or untreated control 
(21.22%±1.83%) in U87MG cells (Table 2). The difference 
between the G2/M phase-arrested cell populations with Cur/
mPEG-OA and untreated control was significant (P0.05).
cur/mPeg-Oa induces apoptosis 
in U87Mg cancer cells 
The Annexin-V-FLUOS and PI staining assay is a test 
that differentiates early apoptosis and necrosis (secondary 
apoptotic cells). The role of curcumin in inducing apop-
tosis has been investigated in numerous studies, and its 
potential to activate different pathways related to apoptosis 
has been demonstrated.29,30 In the present study, U87MG 
cells were exposed to different concentrations of curcumin 
(1 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, and 30 μM of 
curcumin encapsulated in mPEG-OA) for 24 hours. As 
shown in Figure 12, Cur/mPEG-OA induced apoptosis 
in U87MG cells in a concentration-dependent behavior. 
The percentages of early apoptotic cells after 24 hours of 
treatment with 1 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, or 
30 μM curcumin (Cur/mPEG-OA) were determined to be 
9.5%±0.03%, 10.5%±0.04%, 10.81%±0.5%, 12.07%±1%, 
44.53%±2%, and 28.73%±1.5%, respectively. These results 
are in accordance with those of our previous dendrosome 
research,13 which showed apoptosis induction in a time- and 
dose-dependent manner. Additionally, although apoptosis 
can be observed below the IC
50
, it seems that there are no 
significant differences between treatments below 10 μM of 
curcumin (Cur/mPEG-OA). However, treatments with the 
higher concentrations, for example 20 μM or 30 μM, of which 
the latter is higher than the IC
50
 (24 μM), significantly induce 
apoptosis. It should be noted that treatment with 30 μM cur-
cumin caused early apoptosis to be changed to late apoptosis 
(Figure 12). Increasing the curcumin concentration from 
20 μM to 30 μM obviously induced late apoptosis in the cells. 
At the 20 μM concentration, 44.53%±2% and 4.21%±1.5% 
of the cell populations were in early and late apoptosis, 
respectively, whereas at 30 μM, the percentages changed 
to 28.73%±3.8% and 40.12%±4.5%, respectively. Interest-
ingly, similar to the MTT assay results, blank mPEG-OA at 
50 μM had no cytotoxic effect on the cells and, therefore, no 
necrosis or apoptosis was observed following this treatment 
(Figure 12). Finally, with no necrosis-inducing effect and 
a structure similar to the dendrosome structures,13 it seems 
that this mPEG-OA formulation can be considered a safe 
nanocarrier for curcumin delivery to cancer cells.
Conclusion
This research demonstrates that micelles and polymersomes 
coexist even at very high ratios (ƒ≈85%) of hydrophilic 
parts to the total mass of copolymer blocks. It was shown 
in this study that micelles and polymersomes can form 
simultaneously from amphiphilic block copolymers, and 
the proportion of micelle/polymersome formation depends 
on the concentration of the block copolymer used. A higher 
concentration increases the number of micelles, and a lower 
concentration results in the formation of more favorable and 
thermodynamically stable polymersomes. It remains unclear 
whether the mPEG-OA polymersomes have any significant 
biological importance. The results for cell toxicity implied 
that micelles may be primarily responsible for the anticancer 
effect of the delivery system and were probably more impor-
tant than polymersomes in mPEG-OA structures. However, 
new dendrosome structure modifications, such as using mPEG 
instead of PEG and a higher PEG molecular weight (2,000 
Da) instead of a low-molecular weight (500 Da), changed 
the anticancer properties of the curcumin cargo in favor of 
more selective cancer cell toxicity. Finally, with no necrotic 
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U87MG cancer cell line (fluorescence microscopy)
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Figure 11 Fluorescence microscopy images of cur/mPeg-Oa nanocarriers.
Notes: Visible light (left column) and fluorescence (right column) images of Cur/mPEG-OA nanocarriers. Each pair of the left and right image is the same section of the cells 
pictured at the similar time points. Images show that free curcumin (solubilized with 1% methanol) and cur/mPeg-Oa (curcumin encapsulated) nanocarriers enter the U87Mg 
cancer cells after 4 hours.
Abbreviation: cur/mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate.
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Table 2 cell-cycle distribution in UM87Mg cells (after 24 hours) 
Sub-G0/G1 G1 S G2/M
0 (control) 1.55±0.55 62.64±2.73 9.91±0.42 21.22±1.83
Free curcumin (30 μM) 3.56±0.07 59.75±0.46 15±0.33 18±0.56
cur/mPeg-Oa (22 μM curcumin) 5.35±0.84* 46.47±1.96 8.9±0.26 32.23±0.8*
Notes: Data are shown as the mean percentages ± standard deviation. *Different from control, P0.05.
Abbreviation: cur/mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate.
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Figure 12 cur/mPeg-Oa-induced apoptosis or necrosis according to annexin-V-FlUOs/PI staining in U87Mg cells after 24 hours of incubation. 
Notes: Viable cells (annexin-V-/PI-), early apoptotic cells (annexin-V+/PI-), necrotic cells (annexin-V-/PI+), and necrotic cells or late apoptotic cells (annexin-V+/PI+) are 
located in the lower left, lower right, upper left, and upper right quadrants, respectively. The numbers in each quadrant represent the percentages of cells.
Abbreviations: mPeg-Oa, monomethoxy poly(ethylene glycol)-oleate; cur/mPeg-Oa, curcumin/monomethoxy poly(ethylene glycol)-oleate; PI, propidium iodide.
effect on the cells (as shown by Annexin/PI evaluation), the 
mPEG-OA formulation can be considered a safe nanocarrier 
for the delivery of curcumin and other small hydrophobic 
molecule drugs. Further studies are currently underway to 
determine the potential of the mPEG-OA formulation for the 
in vivo enhancement of the efficacy of curcumin.
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